Lumexa Imaging Holdings, Inc. Common Stock

NASDAQ:LMRI

Medical - Devices

Healthcare
$14.01 +7.25%

+$0.84 today

Market cap
$1.35B
Beta
2.18
P/E (TTM)
-34.3
EPS (TTM)
-$0.28
52W Low $6.45High $19.45

Volume 0.26M

Average 0.92M

LMRI EBITDA Margin

EBITDA as a percentage of revenue.

Lumexa Imaging Holdings, Inc. Common StockNASDAQ: LMRI

EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026

EBITDA Margin at 13.2%

EBITDA Margin was 13.2% in Q1 FY2026.

Context

  • EBITDA Margin widened in 2 of the last 2 fiscal years.
  • FY2025 was the highest level in the 3 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 7 analysts of 24.4% for the fiscal year ending Dec 2026, up from 13.9% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
13.2%+7.6 pp QoQ
Last fiscal yearDec 2025
13.9%+1.8 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter———
1 year+1.8 pp+10.6 pp+8.7 pp
3 years—+8.9 pp—
5 years+8.8 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
13.9%
Year-over-year change
+1.8pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How LMRI compares with its peers on the latest reported figures

  • LMRI's FY2025 EBITDA Margin of 13.9% is the highest of the 2 companies compared; the peer median is 12.4%.
  • Its year-over-year change of +1.8 pp is the highest of 2, against a peer median of -2.9 pp.
LMRI Competitors Peer median
EBITDA Margin for LMRI and competitors
Company Period LTM level YoY 3-year change
LMRILumexa Imaging Holdings, Inc. Common StockFY202513.9% +1.8 pp—
RDNTRadNet, Inc.LTM Sep 202612.4% -2.9 pp-7.0 pp
Peer median (excluding LMRI) 12.4%-2.9 pp-7.0 pp

Competitors are the stored peer set for LMRI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue935.93M948.87M1.02B
Cost of Revenue836.96M852.61M905.9M
Gross Profit98.97M96.26M117.19M
Gross Margin10.6%10.1%11.5%
Research & Development000
Selling, General & Admin55.17M70.36M90.45M
Operating Expenses76.52M41.02M90.45M
Depreciation & Amortization72.14M57.16M55.39M
EBITDA94.58M114M141.71M
EBITDA Margin10.1%12.0%13.9%
Operating Income22.45M55.24M26.73M
Operating Margin2.4%5.8%2.6%
Interest Income000
Interest Expense141.69M136.03M118.54M
Other Income / Expenses(141.69M)(134.44M)(58.95M)
Income Before Tax(119.25M)(79.19M)(32.22M)
Pre-Tax Margin-12.7%-8.3%-3.1%
Income Tax Expense2.98M14.91M14.89M
Net Income(122.23M)(94.1M)(47.1M)
Net Margin-13.1%-9.9%-4.6%
EPS (Basic)(1.29)(1.00)(0.66)
EPS (Diluted)(1.29)(1.00)(0.66)
Weighted Avg Shares94.57M94.57M70.98M
Weighted Avg Shares (Diluted)94.57M94.57M70.98M

Lumexa Imaging Holdings, Inc. Common Stock

NASDAQ:LMRI

Intrinsic Alpha fair value

Locked

Current Price

$14.01

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.